1. Home
  2. Labeler Index
  3. Contract Pharmacy Services-pa
  4. 67046-082
  5. NDC Package Code: 67046-082-30 Bupropion Hydrochloride

NDC Package 67046-082-30 Bupropion Hydrochloride

View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
67046-082-30
Package Description:
30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
Product Code:
67046-082
Proprietary Name:
Bupropion Hydrochloride
Usage Information:
Bupropion hydrochloride extended-release tablets (XL) are contraindicated in patients with seizure disorder.Bupropion hydrochloride extended-release tablets (XL) are contraindicated in patients with a current or prior diagnosis of bulimia or anorexia nervosa as a higher incidence of seizures was observed in such patients treated with bupropion hydrochloride extended-release tablets (XL) [see Warnings and Precautions ( 5.3) ] .Bupropion hydrochloride extended-release tablets (XL) are contraindicated in patients undergoing abrupt discontinuation of alcohol, benzodiazepines, barbiturates, and antiepileptic drugs [see Warnings and Precautions ( 5.3) and Drug Interactions ( 7.3) ]. The use of MAOIs (intended to treat psychiatric disorders) concomitantly with bupropion hydrochloride extended-release tablets (XL) or within 14 days of discontinuing treatment with bupropion hydrochloride extended-release tablets (XL) is contraindicated. There is an increased risk of hypertensive reactions when bupropion hydrochloride extended-release tablets (XL) are used concomitantly with MAOIs. The use of bupropion hydrochloride extended-release tablets (XL) within 14 days of discontinuing treatment with an MAOI is also contraindicated. Starting bupropion hydrochloride extended-release tablets (XL) in a patient treated with reversible MAOIs such as linezolid or intravenous methylene blue is contraindicated [see Dosage and Administration ( 2.9), Warnings and Precautions ( 5.4) and Drug Interactions ( 7.6) ]. Bupropion hydrochloride extended-release tablets (XL) are contraindicated in patients with known hypersensitivity to bupropion or other ingredients of bupropion hydrochloride extended-release tablets (XL). Anaphylactoid/anaphylactic reactions and Stevens-Johnson Syndrome have been reported [see Warnings and Precautions ( 5.8) ].
11-Digit NDC Billing Format:
67046008230
NDC to RxNorm Crosswalk:
  • RxCUI: 993541 - buPROPion HCl 150 MG 24HR Extended Release Oral Tablet
  • RxCUI: 993541 - 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet
  • RxCUI: 993541 - bupropion HCl XL 150 MG 24 HR Extended Release Oral Tablet
    • Labeler Name:
    Contract Pharmacy Services-pa
    Sample Package:
    No
    Start Marketing Date:
    09-28-2017
    Listing Expiration Date:
    12-31-2019
    Exclude Flag:
    I
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    67046-082-077 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
    67046-082-1414 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
    67046-082-1515 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
    67046-082-2020 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
    67046-082-2121 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
    67046-082-2828 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
    67046-082-6060 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 67046-082-30?

    The NDC Packaged Code 67046-082-30 is assigned to a package of 30 tablet, film coated, extended release in 1 blister pack of Bupropion Hydrochloride, labeled by Contract Pharmacy Services-pa. The product's dosage form is and is administered via form.

    Is NDC 67046-082 included in the NDC Directory?

    No, Bupropion Hydrochloride with product code 67046-082 is excluded from the NDC Directory because it's listing has been INACTIVATED by FDA. The product was first marketed by Contract Pharmacy Services-pa on September 28, 2017 and its listing in the NDC Directory is set to expire on December 31, 2019 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 67046-082-30?

    The 11-digit format is 67046008230. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-267046-082-305-4-267046-0082-30